Loading...
137 Australia Chronic Disorder Drugs Reports
Country Covered: Australia
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Merck & Co. Inc., Bayer AG, Amgen Inc, AstraZeneca, Johnson & Johnson Services, Inc.
Country Covered: Australia
Study Period: 2018 - 2029
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: AbbVie Inc., Pfizer Inc., Teva Pharmaceutical, Sun Pharmaceutical Industries Ltd, Novartis AG
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janssen
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: AstraZeneca PLC, Bayer AG, F. Hoffmann La-Roche Ltd, Teva Pharmaceutical Industries Ltd, Seagen Inc
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Merck KGaA, Johnson and Johnson, Pfizer, Inc.
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, SymBio Pharmaceuticals Limited, Genmab AS
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Johnson & Johnson (Janssen Pharmaceuticals Inc.), Novartis AG, Bristol Myers Squibb Company, Merck & Co. Inc, F. Hoffmann-La Roche Ltd
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Bristol Myers Squibb, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, GlaxoSmithKline (GSK) PLC
Country Covered: Australia
Study Period: 2021 - 2029
Major Players: Pfizer Inc., Novartis AG, Sanofi-Aventis (Genzyme Corporation), Otsuka holdings co., ltd., Bristol Myers Squibb
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Amgen Inc., AstraZeneca PLC, Hoffmann-La Roche AG, Eli Lilly and Company , GSK plc
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Abbvie, F. Hoffmann-La Roche Ltd
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Amgen Inc., Bausch Health Companies Inc., Novartis AG, AbbVie Inc., Almirall SA
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company
Country Covered: Australia
Study Period: 2020 - 2029
Major Players: Amgen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Novartis International AG, Sanofi S.A.
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Amgen, Bayer AG, Pfizer Inc., Novartis International AG, Johnson and Johnson
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Eli Lilly and Company, Pfizer Inc., Johnson and Johnson (Janssen Global Services, LLC), Novartis AG, Amgen Inc.
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Bristol‑Myers Squibb Company, Eisai Co., Ltd., Exelixis Inc, Merck & Co. Inc., Bayer AG
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Baxter International, Inc., GlaxoSmithKline PLC, Pfizer, Inc., Johnson & Johnson, Novartis AG
Country Covered: Australia
Study Period: 2021 - 2029
Major Players: Teva Pharmaceuticals, L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique), Sun Pharmaceutical Industries, Inc., JOHNSON & JOHNSON, Abbvie Inc (Allergan PLC)
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Novartis AG, Merck Co & Inc., Fresenius Kabi, Pfizer Inc., Eli Lilly & Co.
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Vivus, F Hoffmann-La Roche AG, GlaxoSmithKline PLC, Novo Nordisk AS, Currax Pharmaceuticals LLC
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche Ltd, Celltrion Inc., Merck & Co
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc.,, Novartis AG, Bausch Health Companies Inc. , Johnson & Johnson
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Bristol-Myers Squibb Company, Merck & Co. Inc., Biogen Inc., Amneal Pharmaceuticals, Inc., Seagen Inc.
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: GlaxoSmithKline Plc, Merck & Co Inc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Novartis AG
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Bayer AG, F. Hoffmann-La Roche Ltd, Eisai Inc., Novartis AG, Merck & Co. Inc.
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Elekta AB, Karyopharm Therapeutics, Eisai Co., Ltd., GSK plc, Siemens Healthineers (Varian Medical Systems, Inc.)
Country Covered: Australia
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company